1,243
Views
3
CrossRef citations to date
0
Altmetric
Clinical Study

Value of the high-sensitivity troponin T assay for diagnosis of acute myocardial infarction in patients with and without renal insufficiency

ORCID Icon, , , , ORCID Icon, , & show all
Pages 1142-1151 | Received 14 Jul 2020, Accepted 28 Oct 2020, Published online: 12 Nov 2020

References

  • Thygesen K, Alpert JS, Jaffe AS, et al.; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618–e651.
  • Murray J, Balmuri A, Saurav A, et al. Impact of chronic kidney disease on utilization of coronary angiography and percutaneous coronary intervention, and their outcomes in patients with non-ST elevation myocardial infarction. Am J Cardiol. 2018;122(11):1830–1836.
  • Vashistha V, Lee M, Wu YL, et al. Low glomerular filtration rate and risk of myocardial infarction: a systematic review and meta-analysis. Int J Cardiol. 2016;223:401–409.
  • Smilowitz NR, Gupta N, Guo Y, et al. Management and outcomes of acute myocardial infarction in patients with chronic kidney disease. Int J Cardiol. 2017;227:1–7.
  • Aoki T, Ishii H, Tanaka A, et al. Influence of chronic kidney disease and worsening renal function on clinical outcomes in patients undergoing primary percutaneous coronary intervention. Clin Exp Nephrol. 2019;23(2):182–188.
  • Bhatia S, Arora S, Bhatia SM, et al. Non-ST-segment-elevation myocardial infarction among patients with chronic kidney disease: a propensity score-matched comparison of percutaneous coronary intervention versus conservative management. J Am Heart Assoc. 2018;7(6):e007920.
  • Shroff GR, Frederick PD, Herzog CA. Renal failure and acute myocardial infarction: clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System/National Institutes of Health and the National Registry of Myocardial Infarction. Am Heart J. 2012;163(3):399–406.
  • Hawranek M, Gierlotka M, Gąsior M, et al. Renal function on admission affects both treatment strategy and long-term outcomes of patients with myocardial infarction (from the Polish Registry of Acute Coronary Syndromes). Kardiol Pol. 2017;75(4):332–343.
  • Wang HT, Chen YL, Wu CJ. Impact of chronic kidney disease on clinical outcomes in patients with non-ST elevation myocardial infarction receiving percutaneous coronary intervention – A five-year observational study. Int J Cardiol. 2016;220:166–172.
  • Patel B, Shah M, Dusaj R, et al. Percutaneous coronary intervention and inpatient mortality in patients with advanced chronic kidney disease presenting with acute coronary syndrome. Proc (Bayl Univ Med Cent). 2017;30(4):400–403.
  • Nakahashi H, Kosuge M, Sakamaki K, et al. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention. Heart Vessels. 2017;32(1):22–29.
  • Wang AY, Wai-Kei Lam C. The diagnostic utility of cardiac biomarkers in dialysis patients. Semin Dial. 2012;25(4):388–396.
  • Middleton PM. Practical use of the Glasgow Coma Scale; a comprehensive narrative review of GCS methodology. Australas Emerg Nurs J. 2012;15(3):170–183.
  • Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–735.
  • DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–845.
  • Thygesen K, Alpert JS, Jaffe AS, et al.; Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020–2035.
  • Sieweke N, Allendorfer J, Franzen W, et al. Cardiac Troponin I elevation after epileptic seizure. BMC Neurol. 2012;12:58.
  • Morrow DA, Bonaca MP. Real-world application of "delta" troponin: diagnostic and prognostic implications. J Am Coll Cardiol. 2013;62(14):1239–1241.
  • McLaurin MD, Apple FS, Voss EM, et al. Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. Clin Chem. 1997;43(6 Pt 1):976–982.
  • Egholm G, Pareek M. Drug-induced rhabdomyolysis with elevated cardiac troponin T. Case Rep Med. 2015;2015:270204.
  • deFilippi CR, Herzog CA. Interpreting cardiac biomarkers in the setting of chronic kidney disease. Clin Chem. 2017;63(1):59–65.
  • Apple FS, Murakami MM, Pearce LA, et al. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation. 2002;106(23):2941–2945.
  • Chotivanawan T, Krittayaphong R. Normal range of serum highly-sensitive troponin-T in patients with chronic kidney disease stage 3-5. J Med Assoc Thai. 2012;95 (Suppl 2):S127–S132.
  • Tarapan T, Musikatavorn K, Phairatwet P, et al. High sensitivity Troponin-I levels in asymptomatic hemodialysis patients. Ren Fail. 2019;41(1):393–400.
  • Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361(9):858–867.
  • Weber M, Bazzino O, Navarro Estrada JL, et al. Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. Am Heart J. 2011;162(1):81–88.
  • Huang H, Zhu S, Wang W, et al. Diagnosis of acute myocardial infarction in patients with renal insufficiency using high-sensitivity troponin T. Clin Chem Lab Med. 2015;53(5):723–730.
  • Pfortmueller CA, Funk GC, Marti G, et al. Diagnostic performance of high-sensitive troponin T in patients with renal insufficiency. Am J Cardiol. 2013;112(12):1968–1972.
  • Huang HL, Zhu S, Wang WQ, et al. Diagnosis of acute myocardial infarction in hemodialysis patients with high-sensitivity cardiac troponin T assay. Arch Pathol Lab Med. 2016;140(1):75–80.
  • Twerenbold R, Wildi K, Jaeger C, et al. Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction. Circulation. 2015;131(23):2041–2050.
  • Kraus D, von Jeinsen B, Tzikas S, et al. Cardiac troponins for the diagnosis of acute myocardial infarction in chronic kidney disease. J Am Heart Assoc. 2018;7(19):e008032.
  • Reichlin T, Irfan A, Twerenbold R, et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation. 2011;124(2):136–145.
  • Reiter M, Twerenbold R, Reichlin T, et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J. 2011;32(11):1379–1389.
  • Reiter M, Twerenbold R, Reichlin T, et al. Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J. 2012;33(8):988–997.